Pegintron and Pancreatitis aggravated - a phase IV clinical study of FDA data


Pancreatitis aggravated is found among people who take Pegintron, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Pegintron and have Pancreatitis aggravated. It is created by eHealthMe based on reports of 10,284 people who have side effects when taking Pegintron from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

10,284 people reported to have side effects when taking Pegintron.
Among them, 26 people (0.25%) have Pancreatitis aggravated.

What is Pegintron?

Pegintron has active ingredients of peginterferon alfa-2b. It is often used in hepatitis c. eHealthMe is studying from 10,315 Pegintron users for its effectiveness, alternative drugs and more.

What is Pancreatitis aggravated?

Pancreatitis aggravated (serious inflammation of pancreas) is found to be associated with 1,526 drugs and 419 conditions by eHealthMe.

Number of Pegintron and Pancreatitis aggravated reports submitted per year:

Could Pegintron cause Pancreatitis aggravated?

Time on Pegintron when people have Pancreatitis aggravated *:

  • < 1 month: 53.85 %
  • 1 - 6 months: 38.46 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 7.69 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Pancreatitis aggravated when taking Pegintron *:

  • female: 26.09 %
  • male: 73.91 %

Age of people who have Pancreatitis aggravated when taking Pegintron *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 10.53 %
  • 50-59: 21.05 %
  • 60+: 68.42 %

Common drugs people take besides Pegintron *:

  1. Rebetol: 19 people, 73.08%
  2. Victrelis: 4 people, 15.38%
  3. Voltaren: 3 people, 11.54%
  4. Ribavirin: 3 people, 11.54%
  5. Nexium: 2 people, 7.69%
  6. Amlodipine Besylate: 2 people, 7.69%
  7. Ribasphere: 2 people, 7.69%
  8. Atazanavir: 1 person, 3.85%
  9. Celexa: 1 person, 3.85%
  10. Cellcept: 1 person, 3.85%

Common side effects people have besides Pancreatitis aggravated *:

  1. Fatigue (feeling of tiredness): 5 people, 19.23%
  2. Fever: 4 people, 15.38%
  3. Anaemia (lack of blood): 4 people, 15.38%
  4. Renal Impairment (severely reduced kidney function): 4 people, 15.38%
  5. Pancreatitis Acute (sudden inflammation of pancreas): 3 people, 11.54%
  6. Drug Eruption (adverse drug reaction of the skin): 3 people, 11.54%
  7. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 11.54%
  8. Abdominal Distension: 2 people, 7.69%
  9. Blood Creatinine Increased: 2 people, 7.69%
  10. Diarrhea: 2 people, 7.69%

Common conditions people have *:

  1. High Blood Pressure: 4 people, 15.38%
  2. Type 2 Diabetes: 2 people, 7.69%
  3. Osteoporosis (bones weak and more likely to break): 2 people, 7.69%
  4. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 7.69%
  5. Gastric Ulcer (stomach ulcer): 2 people, 7.69%
  6. Depression: 2 people, 7.69%
  7. Stomatitis (inflammation of mucous membrane of mouth): 1 person, 3.85%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.85%
  9. Insomnia (sleeplessness): 1 person, 3.85%
  10. Immunodeficiency Disorders: 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Pegintron and have Pancreatitis aggravated?

Check whether Pancreatitis aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Pancreatitis aggravated and when was it recovered:

Expand to all the drugs that have ingredients of peginterferon alfa-2b:

Alternative drugs to, pros and cons of Pegintron:

Common Pegintron side effects:

Browse all side effects of Pegintron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pancreatitis aggravated treatments and more:

COVID vaccines that are related to Pancreatitis aggravated:

Common drugs associated with Pancreatitis aggravated:

All the drugs that are associated with Pancreatitis aggravated:

Common conditions associated with Pancreatitis aggravated:

All the conditions that are associated with Pancreatitis aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on peginterferon alfa-2b (the active ingredients of Pegintron) and Pegintron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: